Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Gut
|
July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
B Helbling, K Overbeck, J-J Gonvers, et al.
Journal of Hepatology
|
March 11, 2014
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
Y-L Liu, G L Patman, J B S Leathart, et al.
Oncogene
|
March 18, 2014
Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility
V Edmond, F Dufour, G Poiroux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2016
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
D Koeberle, J-F Dufour, G Demeter, et al.
Journal of Viral Hepatitis
|
November 18, 2015
Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin
G R Foster, P Ferenci, T Asselah, et al.
Journal of Viral Hepatitis
|
October 15, 2013
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection
A J van der Meer, B J Veldt, J J Feld, et al.
Alimentary Pharmacology & Therapeutics
|
August 24, 2016
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
M Munteanu, D Tiniakos, Q Anstee, et al.
The Pharmacogenomics Journal
|
December 9, 2015
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation
L Quteineh, P-Y Bochud, D Golshayan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 30, 1996
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene
R B Amson, M Nemani, J P Roperch, et al.
Gut
|
September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis C
S Rüeger, P-Y Bochud, J-F Dufour, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Gut
|
July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
B Helbling, K Overbeck, J-J Gonvers, et al.
Journal of Hepatology
|
March 11, 2014
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
Y-L Liu, G L Patman, J B S Leathart, et al.
Oncogene
|
March 18, 2014
Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility
V Edmond, F Dufour, G Poiroux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2016
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
D Koeberle, J-F Dufour, G Demeter, et al.
Journal of Viral Hepatitis
|
November 18, 2015
Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin
G R Foster, P Ferenci, T Asselah, et al.
Journal of Viral Hepatitis
|
October 15, 2013
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection
A J van der Meer, B J Veldt, J J Feld, et al.
Alimentary Pharmacology & Therapeutics
|
August 24, 2016
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
M Munteanu, D Tiniakos, Q Anstee, et al.
The Pharmacogenomics Journal
|
December 9, 2015
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation
L Quteineh, P-Y Bochud, D Golshayan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 30, 1996
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene
R B Amson, M Nemani, J P Roperch, et al.
Gut
|
September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis C
S Rüeger, P-Y Bochud, J-F Dufour, et al.
Page
of 12